Effects of erythromycin on γ-glutamyl cysteine synthetase and interleukin-1β in hyperoxia-exposed lung tissue of premature newborn rats

J Pediatr (Rio J). 2014 Sep-Oct;90(5):493-9. doi: 10.1016/j.jped.2014.01.013. Epub 2014 May 27.

Abstract

Objective: To explore the effect of erythromycin on hyperoxia-induced lung injury.

Methods: One-day-old preterm offspring Sprague-Dawley (SD) rats were randomly divided into four groups: group 1, air + sodium chloride; group 2, air + erythromycin;group 3, hyperoxia + sodium chloride; and group 4, hyperoxia + erythromycin. At one, seven, and 14 days of exposure, glutathione (GSH) and interleukin-1 beta (IL-1 beta) were detected by double-antibody sandwich enzyme-linked immunosorbent assay (ELISA), and bicinchoninic acid (BCA) was used to detect GSH protein. γ-glutamine-cysteine synthetase (γ-GCS) mRNA was detected by reverse transcription-polymerase chain reaction (RT-PCR).

Results: Compared with group 1, expressions of GSH and γ-GCS mRNA in group 3 were significantly increased at one and seven days of exposure (p < 0.05), but expression of γ-GCS mRNA was significantly reduced at 14 days; expression of IL-1 beta in group 3 was significantly increased at seven days of exposure (p < 0.05), and was significantly reduced at 14 days. Compared with group 3, expressions of GSH and γ-GCS mRNA in group 4 were significantly increased at one, seven, and 14 days of exposure (p < 0.05), but expressions of GSH showed a downward trend at 14 days; expression of IL-1 beta in group 4 was significantly reduced at one and seven days of exposure (p < 0.05).

Conclusions: Changes in oxidant-mediated IL-1 beta and GSH are involved in the development of hyperoxia-induced lung injury. Erythromycin may up-regulate the activity of γ-GCS, increasing the expression of GSH, inhibiting the levels of oxidant-mediated IL-1 beta and alleviating hyperoxia-induced lung injury via an antioxidant effect.

Keywords: Eritromicina; Erythromycin; Glutathione; Glutationa; Hiperóxia; Hyperoxia; Interleucina-1 beta; Interleukin-1-beta; Lesão pulmonar; Lung injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Disease Models, Animal
  • Enzyme-Linked Immunosorbent Assay
  • Erythromycin / pharmacology*
  • Female
  • Glutamate-Cysteine Ligase / drug effects*
  • Glutathione / metabolism
  • Hyperoxia / metabolism*
  • Interleukin-1beta / drug effects*
  • Interleukin-1beta / metabolism
  • Lung / drug effects*
  • Lung Injury / metabolism
  • Male
  • Oxygen / metabolism
  • Oxygen / pharmacology
  • Protein Synthesis Inhibitors / metabolism
  • Protein Synthesis Inhibitors / pharmacology*
  • Random Allocation
  • Rats, Sprague-Dawley
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Interleukin-1beta
  • Protein Synthesis Inhibitors
  • Erythromycin
  • Glutamate-Cysteine Ligase
  • Glutathione
  • Oxygen